Found: 22
Select item for more details and to access through your institution.
Association of -463G/A MPO gene polymorphism and risk of cervical intraepithelial neoplasia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vitamin D Analogs Regulate the Vitamin D System and Cell Viability in Ovarian Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 1, p. 172, doi. 10.3390/ijms23010172
- By:
- Publication type:
- Article
Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium.
- Published in:
- Journal of Ovarian Research, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1757-2215-6-42
- By:
- Publication type:
- Article
ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy—Innovative Models Prolong Survival (OCTIPS) Consortium
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer: A Multicenter Retrospective Study by the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 35, doi. 10.1245/s10434-022-12459-3
- By:
- Publication type:
- Article
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 8, p. 1249, doi. 10.1038/s41416-023-02550-1
- By:
- Publication type:
- Article
AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer.
- Published in:
- BMC Genomics, 2016, v. 17, p. 1, doi. 10.1186/s12864-016-3001-y
- By:
- Publication type:
- Article
Co-expressed genes enhance precision of receptor status identification in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 2, p. 313, doi. 10.1007/s10549-018-4920-x
- By:
- Publication type:
- Article
Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer.
- Published in:
- Oncology Letters, 2017, v. 13, n. 6, p. 4047, doi. 10.3892/ol.2017.5969
- By:
- Publication type:
- Article
Decision theory for precision therapy of breast cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82418-7
- By:
- Publication type:
- Article
SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.946348
- By:
- Publication type:
- Article
Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Association of TAP Gene Polymorphisms and Risk of Cervical Intraepithelial Neoplasia.
- Published in:
- Disease Markers, 2013, v. 35, n. 2, p. 79, doi. 10.1155/2013/368732
- By:
- Publication type:
- Article
Microarray Normalization Revisited for Reproducible Breast Cancer Biomarkers.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/1363827
- By:
- Publication type:
- Article
Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1076, doi. 10.3390/cancers13051076
- By:
- Publication type:
- Article
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3828, doi. 10.3390/cancers12123828
- By:
- Publication type:
- Article
Metabolism of Estrogens: Turnover Differs between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 279, doi. 10.3390/cancers12020279
- By:
- Publication type:
- Article
Decision Theory versus Conventional Statistics for Personalized Therapy of Breast Cancer.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 4, p. 570, doi. 10.3390/jpm12040570
- By:
- Publication type:
- Article
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer -- a study.
- Published in:
- OncoTargets & Therapy, 2014, v. 7, p. 1563, doi. 10.2147/OTT.S65373
- By:
- Publication type:
- Article
Fibroblast growth factor receptor 4 gene ( FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 4, p. E586, doi. 10.1002/ijc.27329
- By:
- Publication type:
- Article
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-67
- By:
- Publication type:
- Article